Literature DB >> 16798545

Diagnosing and managing cystic fibrosis in the developing world.

Sushil K Kabra1, M Kabra, S Shastri, R Lodha.   

Abstract

Cystic fibrosis (CF), earlier believed to be non existent in non Caucasians, is now a pan ethnic disease, having being reported from various regions of the world over last one decade. Apart from limited resources, the major problems in diagnosis and management of CF in developing countries include: lack of awareness among pediatricians, absence of facilities for diagnosis (sweat chloride estimation and genetic studies), lack of trained manpower for care of specific problems, and non availability of appropriate drugs. Care of children with CF may not be a priority for governments in countries where childhood mortality rates are high, predominantly due to acute infections. An indigenously developed and relatively inexpensive method of sweat collection and chloride estimation using pilocarpine iontophoresis and titration, respectively, may be an alternative to the commercially available costly equipment. Having a team of trained nurse, physiotherapist, and dietician for optimal care of CF patients may not be feasible due to inadequate resources. Training a single person (e.g. nurse) to deliver comprehensive CF care may be a feasible alternative. To overcome problems of non availability of appropriate drugs (enzymes, inhaled antibiotics, DNAse, etc), locally available drugs may be used. Examples include use of hypertonic saline in place of DNAse, enteric coated enzyme tablets in place of enteric coated spherules, etc. Factors that are associated with decreased survival in CF patients from developing countries are age of onset of symptoms <2 months, severe malnutrition at the time of diagnosis, colonization with Pseudomonas at the time of diagnosis and frequency of pneumonia >4 episodes/year. All these factors can be modified except onset of symptoms before 2 months of age, by early diagnosis and appropriate treatment. Many of the above mentioned hurdles have been successfully overcome by us to establish CF services in a resource-limited setting. We conclude that education of pediatricians about the disease, early diagnosis using indigenous technology and aggressive physiotherapy with nutritional management and judicious use of antibiotics can improve the quality of life and survival in CF patients in resource-limited settings.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16798545     DOI: 10.1016/j.prrv.2006.04.218

Source DB:  PubMed          Journal:  Paediatr Respir Rev        ISSN: 1526-0542            Impact factor:   2.726


  10 in total

Review 1.  Depression Among Caregivers of Children with Cystic Fibrosis: Causes and Solutions.

Authors:  Amit Pathania; S K Kabra
Journal:  Indian J Pediatr       Date:  2018-08-11       Impact factor: 1.967

2.  Assessment of Correlation between Sweat Chloride Levels and Clinical Features of Cystic Fibrosis Patients.

Authors:  Manzoor A Raina; Mosin S Khan; Showkat A Malik; Ab Hameed Raina; Mudassir J Makhdoomi; Javed I Bhat; Syed Mudassar
Journal:  J Clin Diagn Res       Date:  2016-12-01

3.  Defining a mutational panel and predicting the prevalence of cystic fibrosis in oman.

Authors:  Uwe W Fass; Majid Al-Salmani; Said Bendahhou; Ganji Shivalingam; Catherine Norrish; Kallesh Hebal; Fiona Clark; Thomas Heming; Saleh Al-Khusaiby
Journal:  Sultan Qaboos Univ Med J       Date:  2014-07-24

Review 4.  The future of cystic fibrosis care: a global perspective.

Authors:  Scott C Bell; Marcus A Mall; Hector Gutierrez; Milan Macek; Susan Madge; Jane C Davies; Pierre-Régis Burgel; Elizabeth Tullis; Claudio Castaños; Carlo Castellani; Catherine A Byrnes; Fiona Cathcart; Sanjay H Chotirmall; Rebecca Cosgriff; Irmgard Eichler; Isabelle Fajac; Christopher H Goss; Pavel Drevinek; Philip M Farrell; Anna M Gravelle; Trudy Havermans; Nicole Mayer-Hamblett; Nataliya Kashirskaya; Eitan Kerem; Joseph L Mathew; Edward F McKone; Lutz Naehrlich; Samya Z Nasr; Gabriela R Oates; Ciaran O'Neill; Ulrike Pypops; Karen S Raraigh; Steven M Rowe; Kevin W Southern; Sheila Sivam; Anne L Stephenson; Marco Zampoli; Felix Ratjen
Journal:  Lancet Respir Med       Date:  2019-09-27       Impact factor: 30.700

5.  Role of inhaled antibiotics in children and adolescents with cystic fibrosis: Experience from the tertiary care center.

Authors:  Danish Abdul Aziz; Aiza Abbas; Anusha Alam; Namrah Aziz
Journal:  Lung India       Date:  2022 May-Jun

6.  Individualized supervised resistance training during nebulization in adults with cystic fibrosis.

Authors:  Ina Shaw; Janine E Kinsey; Roxanne Richards; Brandon S Shaw
Journal:  Pak J Med Sci       Date:  2016 Sep-Oct       Impact factor: 1.088

7.  Phenotypic spectrum and genetic heterogeneity of cystic fibrosis in Sri Lanka.

Authors:  Neluwa Liyanage Ruwan Indika; Dinesha Maduri Vidanapathirana; Hewa Warawitage Dilanthi; Grace Angeline Malarnangai Kularatnam; Nambage Dona Priyani Dhammika Chandrasiri; Eresha Jasinge
Journal:  BMC Med Genet       Date:  2019-05-24       Impact factor: 2.103

8.  Cystic fibrosis revisited.

Authors:  H Kulkarni; S Kansra; S Karande
Journal:  J Postgrad Med       Date:  2019 Oct-Dec       Impact factor: 1.476

Review 9.  Differential diagnosis of perinatal Bartter, Bartter and Gitelman syndromes.

Authors:  Oluwatoyin Fatai Bamgbola; Youssef Ahmed
Journal:  Clin Kidney J       Date:  2020-10-25

10.  Clinical, genetic and microbiological characterization of pediatric patients with cystic fibrosis in a public Hospital in Ecuador.

Authors:  Yazmina Lascano-Vaca; Esteban Ortiz-Prado; Lenin Gomez-Barreno; Katherine Simbaña-Rivera; Eduardo Vasconez; Alexander Lister; María Emilia Arteaga-Espinosa; Geovanny F Perez
Journal:  BMC Pediatr       Date:  2020-03-06       Impact factor: 2.125

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.